Janux Therapeutics, Inc. (JANX)
14.16
+0.25
(+1.80%)
USD |
NASDAQ |
Jan 09, 16:00
14.15
-0.01
(-0.07%)
After-Hours: 20:00
Janux Therapeutics Research and Development Expense (Annual): 68.39M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Eli Lilly & Co. | 10.99B |
| Ionis Pharmaceuticals, Inc. | 901.53M |
| MannKind Corp. | 45.89M |
| Madrigal Pharmaceuticals, Inc. | 235.62M |
| Editas Medicine, Inc. | 193.44M |